Clinical biomarker workflows in translational research settings often rely on spreadsheet-driven tracking, manual quality control (QC) reconciliation, and loosely integrated systems, resulting in limited state visibility, delayed reporting, and increased operational risk. These challenges are particularly pronounced in multi-day assays such as Luminex-based quantification of Fragile X Messenger Ribonucleoprotein (FMRP), where HIPAA-compliant data governance, deterministic workflow progression, and coordinated communication across laboratory and clinical teams are required.
arXiv:2608. 07627v1 Announce Type: new Abstract: Hospitals are racing to embed AI, while coping with the surge in adaptation of the technology in other industries, into the triage management, documentation, scheduling, and revenue-cycle workflows, yet most deployments remain as fragmented pilots that stall at the edge of production, exposing patients and institutions to operational fragility, ungoverned risk, and mounting technical debt.
By Manideep Dhar, Ritwik Singh, Sharat Chandra Kumar Manikonda
arXiv:2607. 11084v1 Announce Type: new Abstract: Agentic research systems are emerging as a new paradigm for coordinating scientific workflows beyond isolated model inference, code generation, or statistical analysis.
By Eddie Huang (NVIDIA AI Technology Center, NVIDIA Corporation), Ken Liao (NVIDIA AI Technology Center, NVIDIA Corporation), Iven Fu (NVIDIA AI Technology Center, NVIDIA Corporation), Yang-Hsien Lin (NVIDIA AI Technology Center, NVIDIA Corporation), Chao-Shun Zhan (NVIDIA AI Technology Center, NVIDIA Corporation), Andy Liao (NVIDIA AI Technology Center, NVIDIA Corporation), Virginia Chen (NVIDIA AI Technology Center, NVIDIA Corporation), Johnson Sun (NVIDIA AI Technology Center, NVIDIA Corporation), Pika Wang (NVIDIA AI Technology Center, NVIDIA Corporation), Richard Huang (NVIDIA AI Technology Center, NVIDIA Corporation), Jiun-Cheng Jiang (NVIDIA AI Technology Center, NVIDIA Corporation), Ting-Yuan Liu (Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, Master Program for Digital Health Innovation, China Medical University, Taichung, Taiwan), Hsing-Fang Lu (Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, Laboratory for Statistical and Translational Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan), Ray Y. Lee (AI-Driven Genomic Medicine and Drug Discovery Lab, China Medical University Hospital, Taichung, Taiwan), Chi-Chou Liao (Department of Medical Research, China Medical University Hospital, Taichung, Taiwan), Simon See (NVIDIA AI Technology Center, NVIDIA Corporation), Fuu-Jen Tsai (Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, Department of Medical Laboratory Science and Biotechnology, Asia University, Taichung, Taiwan)